Clearstone Central Laboratories Debuts
MDS Pharma Services' Central Labs business will now be known as Clearstone Central Laboratories, and becomes part of Czura Thornton's Life Sciences Group.
In a joint statement, Czura Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to augment our Life Sciences Group with Clearstone Central Laboratories and the deep expertise of the people there. We intend to maintain the integrity of the operational teams and continue to invest in strengthening the company's focus on exceptional client service. Combined with our renewed focus on the consistent delivery of high quality service, flexibility and responsiveness that private ownership allows, we look forward to expanding Clearstone's market reach." Czura Thornton also owns the CRO Chiltern, as well as other interests in life sciences, international trade, property and automtive sectors. This article discusses Czura Thornton's plans for Clearstone moving forward.
Clearstone Central Laboratories is a large private Global Central Laboratory companies solely focused on clinical research and cardiac services. Through a network of wholly owned CAP certified laboratories, Clearstone offers central laboratory services in the Americas, Europe and Asia, which are all equivalently equipped and harmonized to provide consistent, dependable results across programs, study phases and geographies. In addition, Clearstone leverages information technology tools aligned with value add project management principles for managing global clinical trials. Each of its laboratories utilizes the company's centralized APOLLO-CLPM™ (Central Laboratory Protocol Manager) enabling Clearstone project management teams with real-time visibility to component and test level data. Viq Pervaaz, Vice President of Global Project Management commented, "We facilitate our strong project management and data management teams with innovative technology solutions and an advanced web based protocol management system to meet the needs of our clients."
Clearstone Central Laboratories has over 600 employees and facilities in Paris, Hamburg, Toronto, New Jersey, *Beijing and Singapore.
For further information see www.clearstonelabs.com.
*The acquisition of the China business is pending subject to receipt of required Chinese governmental approvals.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
